CooperCompanies Stock - Analyst views and technical picture on a quiet news day
18.06.2026 - 19:54:09 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:52 UTC. Details in the imprint.
CooperCompanies (US21664P1039) draws no new corporate headlines from its investor relations page or major newswires today. Instead, the stock’s setup is defined by a solid analyst consensus and a technical picture shaped by its medium-term moving averages.
Background and data on CooperCompanies stock
All current figures, older news and price data on CooperCompanies stock are bundled on our topic page and on the company’s investor relations site.
How analysts rate the stock
CooperCompanies is covered by a broad group of US and European brokers, with data aggregators showing a predominantly positive stance and a consensus recommendation in the Buy range. Typical twelve-month targets cluster meaningfully above the current share price in US dollar terms.
The company’s last reported quarter, for the three months ended 04/30/2024, delivered mid-single-digit revenue growth and margin resilience in its contact lens and women’s health businesses, which analysts cite as a key driver for their constructive view. Several houses highlight recurring revenue from specialty lenses as a stabilizing element.
What the chart picture shows
On the Nasdaq, CooperCompanies shares trade comfortably above their 52-week low but below their recent peak, leaving the chart in a mid-range consolidation. As of the latest quote, the stock changes hands around the low $360s, implying a mid-teens forward earnings multiple.
Technical data from market portals indicate that the shares hover not far from the 200-day moving average, a level many investors watch as a medium-term trend line. Volatility over recent weeks has been moderate compared with some higher-beta healthcare names in the Standard & Poor's 500 index.
The product behind the stock
CooperCompanies earns most of its revenue through CooperVision, a global supplier of soft contact lenses across daily disposable, toric and multifocal categories, and CooperSurgical, which provides women’s health, fertility and medical device products. This mix ties the company to long-term trends in vision correction and reproductive health.
Where the stock trades today
The shares of CooperCompanies (US21664P1039) trade on Nasdaq at $362.40 as of 06/18/2026, 17:30 UTC.
Key facts on CooperCompanies stock
- Company: CooperCompanies Inc.
- ISIN: US21664P1039
- WKN: A2P4QW
- Ticker: COO
- Venue: Nasdaq
- Price (as of 06/18/2026, 17:30 UTC): 362.40 USD
- Market cap: 18,900,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Medical Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: 08/29/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
